You are here

Article Text

Article menu
Download PDFPDF
LETTER
An international replication, and the need for long term follow up studies
  1. Z Vekerdy1,
  2. L Lakatos2,
  3. G Balla3,
  4. G Oroszlan4
  1. 1National Institute for Medical Rehabilitation, Department of Children’s Rehabilitation, Budapest, Hungary
  2. 2Kenezy County Hospital, Debrecen, Bartók, Hungary
  3. 3NICU, University Medical School, Debrecen, Hungary
  4. 4Markusovszky County Hospital, Szombathely, Hungary
  1. Correspondence to:
    Professor Lakatos
    Kenezy County Hospital, Debrecen, Bartók B.u. 2-26., H-4043; lakatosl{at}kenezykorhaz.hu

https://doi.org/10.1136/adc.2006.096362

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In 1999, a provocative letter was published in your journal1 concerning the use of d-penicillamine (DPA) in the neonatal period. The following statement was written: “Why, then, we wonder, has the demonstration of an effective mode of prevention of retinopathy of prematurity (ROP) in two randomised trials conducted more than 10 years ago in Hungary,2 failed to encourage others to undertake the independent replications needed to verify or refute such a promising approach?”

    Now, we …

    View Full Text

    Footnotes

    • Competing interests: None declared.